Target intelligence / Profile preview

Nucleoporin-62 C-terminal-like protein (NUP62CL)

Target
NUP62CL
Molecular classification
Other (Nucleoporin family, specifically NSP1/NUP62 family; structural component of nuclear pore complex)
01

Overview

Nucleoporin-62 C-terminal-like protein (NUP62CL) is a protein-coding gene product that belongs to the nucleoporin family, specifically the NSP1/NUP62 subgroup. It contains domains found in glycoproteins of nuclear pore complexes, which are large structures spanning the nuclear envelope and facilitating regulated transport of macromolecules between the nucleus and cytoplasm. NUP62CL is a paralog of nucleoporin 62 (NUP62), and is a structural constituent of the nuclear pore complex without direct enzymatic or receptor function. Recent research has identified NUP62CL as significantly upregulated in oral squamous cell carcinoma (OSCC), associated with advanced tumor stage, poor patient prognosis, and high expression of immune checkpoint molecules, suggesting a potential role as a prognostic and immunological biomarker, although it is not currently a therapeutic target. NUP62CL interacts with other nucleoporins such as NUP54, NUP88, NUP93, and components of the nuclear pore complex required for trafficking across the nuclear membrane. Alternative splicing yields multiple transcript variants of the protein. No known drugs are reported to interact with NUP62CL, and its molecular and clinical characterization as a therapeutic target remains unestablished.

Other names
NUP62CLNUP62LNucleoporin-62 C-terminal-like proteinNucleoporin 62kDa C-terminal likeFLJ20130
02

Mechanism of action

Null (no drugs currently known to target NUP62CL)

03

Biological functions

Structural constituent of nuclear poreNuclear-cytoplasmic transport (component of nuclear pore complex, facilitates shuttling of macromolecules between nucleus and cytoplasm)
04

Disease associations

Cancer (Upregulated and associated with poor prognosis in oral squamous cell carcinoma)Other (potential relevance in other cancers/human diseases not currently well-established)
05

Biomarkers

Prognostic biomarker in oral squamous cell carcinoma (OSCC), associated with poor survival and advanced tumor stage, and correlated with immune checkpoint molecules PD-1, PD-L1, and CTLA-4

Beyond the preview

Go deeper on Nucleoporin-62 C-terminal-like protein (NUP62CL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleoporin-62 C-terminal-like protein (NUP62CL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call